BioRestorative Therapies, Inc. - 8-K Filing

BioRestorative Therapies announced a 1-for-20 reverse stock split to regain Nasdaq compliance, effective September 7, 2026. (Items: 3.03 Material Modification to Rights of Security Holders, 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $BRTX

Read the full article at SEC EDGAR

More Regulatory news